Constellation Investments’s Biogen BIIB Stock Holding History

Constellation Investments’s Portfolio BIIB Stock Details BIIB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q1	$2.75M	Buy	10,570 +100	+1%	+$26.4K	0.5%	45
2015 Q4	$3.21M	Sell	10,470 -450	-4%	-$129K	0.6%	38
2015 Q3	$3.19M	Buy	10,920 +25	+0.2%	+$8.26K	0.66%	32
2015 Q2	$4.4M	Buy	10,895 +125	+1%	+$50.2K	0.84%	21
2015 Q1	$4.55M	Buy	10,770 +275	+3%	+$108K	0.87%	21
2014 Q4	$3.56M	Buy	10,495 +300	+3%	+$97.1K	0.72%	26
2014 Q3	$3.37M	Sell	10,195 -50	-0.5%	-$16.5K	0.75%	27
2014 Q2	$3.23M	Sell	10,245 -50	-0.5%	-$15K	0.75%	25
2014 Q1	$3.15M	Buy	10,295 +500	+5%	+$159K	0.77%	26
2013 Q4	$2.74M	Buy	9,795 +600	+7%	+$155K	0.7%	30
2013 Q3	$2.21M	Buy	9,195 +550	+6%	+$123K	0.68%	34
2013 Q2	$1.86M	Buy	+8,645	New	+$1.85M	0.64%	34

Other funds holding BIIB

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return

Constellation Investments's BIIB Position: Q1 2016 in Review

Constellation Investments increased its Biogen (BIIB) stake by 0.96% in Q1 2016, buying an estimated $26.4K and bringing the position to 10,570 shares worth $2.75M. The position accounts for 0.5% of the portfolio, ranked #45.

Constellation Investments first reported a position in BIIB in Q2 2013 and has held it in 12 quarters since. The position peaked at $4.55M in Q1 2015. 948 funds tracked by Wall St. Rank hold BIIB as of Q1 2016.

Constellation Investments held 10,570 shares of Biogen worth $2.75M as of Q1 2016.
Constellation Investments bought 100 Biogen shares in Q1 2016, an estimated $26.4K.
Biogen made up 0.5% of Constellation Investments's portfolio in Q1 2016, its #45 holding.
Constellation Investments first reported a position in Biogen in Q2 2013 and has held it in 12 quarters since.
Constellation Investments's Biogen position peaked at $4.55M in Q1 2015.
948 funds tracked by Wall St. Rank held Biogen as of Q1 2016.

Based on Constellation Investments's 13F filing for Q1 2016, filed 28 Apr 2016.